HomePIRS • NASDAQ
add
Pieris Pharmaceuticals Inc
Previous close
$0.16
Day range
$0.15 - $0.17
Year range
$0.14 - $1.01
Market cap
15.09M USD
Avg Volume
921.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.30M | -77.78% |
Operating expense | 2.33M | -41.61% |
Net income | -4.58M | 43.42% |
Net profit margin | -352.89 | -154.63% |
Earnings per share | — | — |
EBITDA | -5.01M | 54.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 26.37M | -55.44% |
Total assets | 38.68M | -59.49% |
Total liabilities | 11.92M | -82.35% |
Total equity | 26.76M | — |
Shares outstanding | 98.94M | — |
Price to book | 0.58 | — |
Return on assets | -27.95% | — |
Return on capital | -39.40% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.58M | 43.42% |
Cash from operations | -19.67M | -52.08% |
Cash from investing | 3.45M | 211.56% |
Cash from financing | 14.00K | -84.95% |
Net change in cash | -15.50M | -58.34% |
Free cash flow | -5.85M | 28.28% |
About
Founded
2001
Headquarters
Website
Employees
48